Book Cover
Home  |   Healthcare   |  Automated Breast Ultrasound Market

Automated Breast Ultrasound Market Size, Share, Growth, and Industry Analysis, By Type (Automated Breast Ultrasound System, Automated Breast Volume Scanner), By Application (Hospitals, Diagnostic Imaging Laboratories), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US

Automated Breast Ultrasound Market Overview

The global Automated Breast Ultrasound Market is projected to experience sustained growth from USD 1593.39 Million in 2026 to USD 5189.84 Million by 2035, exhibiting a CAGR of 14.02% during the forecast period 2026-2035.

The Automated Breast Ultrasound Market is expanding as healthcare providers strengthen breast cancer screening and diagnostic imaging capabilities. Automated systems capture standardized breast images, improving examination consistency and supporting supplemental assessment of dense breast tissue. Approximately 40% of women undergoing mammography have dense breasts, creating significant demand for complementary imaging techniques. Automated ultrasound provides volumetric visualization without ionizing radiation and can support radiologists in identifying abnormalities that may be difficult to distinguish using mammography alone. Manufacturers are introducing artificial intelligence, automated scanning protocols, and improved image reconstruction tools. Growing screening awareness, expanding diagnostic infrastructure, and increasing demand for personalized breast healthcare are supporting adoption across hospitals and specialized imaging facilities.

The USA Automated Breast Ultrasound Market benefits from established breast screening programs, advanced diagnostic infrastructure, and increasing awareness of breast density. North America represented approximately 45% of the global market in a published 2025 assessment, with the United States contributing substantially to regional demand. Federal breast density notification requirements are encouraging discussions about supplemental screening among patients and healthcare professionals. Hospitals and diagnostic imaging laboratories are evaluating automated ultrasound systems to improve examination standardization and workflow efficiency. Manufacturers are introducing artificial intelligence and remote image review capabilities to support radiologists. Clinical adoption nevertheless depends on appropriate patient selection, reimbursement conditions, professional training, and integration with established mammography services.

Global Automated Breast Ultrasound Market Size, 2035 (USD Million)

Get Comprehensive Insights into the Market’s Size and Growth Trends

downloadDownload FREE Sample

Key Findings

  • Key Market Driver: Increasing awareness of dense breast tissue and demand for supplemental screening support market growth. Approximately 40% of women undergoing mammography have dense breasts, creating opportunities for automated ultrasound examinations.
  • Major Market Restraint: Equipment acquisition requirements, specialist training, and interpretation complexity influence adoption. Automated breast ultrasound screening can generate additional recalls, with published studies reporting recall rates around 10% under certain clinical protocols.
  • Emerging Trends: Artificial intelligence is improving automated scanning and image interpretation efficiency. GE HealthCare reported a 33% reduction in reading time using its AI-assisted breast ultrasound review technology under evaluated conditions.
  • Regional Leadership: North America maintains market leadership with approximately 45% share in a published market assessment, supported by developed breast screening infrastructure, established imaging networks, regulatory awareness, and advanced diagnostic technology adoption.
  • Competitive Landscape: General Electric Company maintains a leading position in the Automated Breast Ultrasound Market with approximately 21% market share, supported by its advanced Invenia ABUS technology, artificial intelligence integration, and established diagnostic imaging presence.
  • Market Segmentation: Automated Breast Ultrasound System leads the supplied product categories with approximately 63% share in a published product assessment, while Hospitals remain important purchasers of automated imaging equipment.
  • Recent Development: Hologic, Inc. highlighted new evidence supporting artificial intelligence in breast imaging. Its technology identified 43% of certain invasive lobular cancer cases previously interpreted as negative during screening.

The Automated Breast Ultrasound Market is experiencing increasing integration of artificial intelligence into image acquisition, examination quality assessment, and radiologist interpretation. Advanced software can identify anatomical landmarks, improve scan consistency, and assist with lesion evaluation. GE HealthCare reported a 33% reduction in reading time with its AI-assisted automated breast ultrasound review technology during evaluated workflows. These capabilities are particularly valuable for imaging departments handling growing examination volumes and limited specialist availability. Automated scanning also supports reproducibility by reducing dependence on individual operator techniques. Manufacturers are improving transducer design, image reconstruction, and workstation interfaces to simplify examinations. Cloud-enabled review systems are additionally supporting collaboration between diagnostic facilities and specialist radiologists.

Another important trend involves expanding supplemental breast imaging for women with dense breast tissue. Clinical research indicates that approximately 40% of women undergoing mammography have dense breasts, although prevalence varies with age and population characteristics. Dense tissue can reduce mammographic visibility and is independently associated with increased breast cancer risk. Automated ultrasound provides additional anatomical information without exposing patients to ionizing radiation. Healthcare providers are developing screening pathways that combine mammography with selected supplemental examinations according to clinical risk. Remote reporting, standardized scanning protocols, and improved patient positioning are becoming important purchasing considerations. However, automated ultrasound remains a complementary imaging method rather than a universal replacement for established breast screening technologies.

Automated Breast Ultrasound Market Dynamics

Driver

"Increasing demand for supplemental breast cancer screening supports market expansion."

Growing awareness of breast cancer detection represents an important driver of the Automated Breast Ultrasound Market. Dense breast tissue presents challenges because abnormalities and normal fibroglandular structures can have similar mammographic appearances. Clinical studies indicate that approximately 40% of women undergoing mammography have dense breasts. Automated ultrasound can provide additional information through standardized volumetric imaging, helping radiologists evaluate selected patients who may benefit from supplemental assessment. Increasing patient awareness and more consistent breast density reporting are encouraging healthcare providers to examine complementary screening strategies. Hospitals are also investing in diagnostic technologies designed to improve workflow consistency and examination accessibility.

Advances in automated imaging technology further support adoption by improving clinical efficiency and examination reproducibility. GE HealthCare's Invenia ABUS Prime incorporates scanning features that can improve scan speed by up to 40% compared with an earlier system configuration. Faster image acquisition may help facilities improve appointment scheduling while reducing patient positioning time. Automated protocols can also support consistent anatomical coverage across examinations. Hospitals and imaging laboratories increasingly evaluate equipment according to image quality, operator training requirements, and integration with existing reporting systems. These improvements strengthen the practical value of automated ultrasound within organized breast imaging programs.

Restraint

"High implementation requirements and additional diagnostic recalls restrict adoption."

Equipment acquisition, installation, training, and operational integration remain important restraints within the Automated Breast Ultrasound Market. Automated examinations require suitable imaging rooms, trained technologists, radiologist interpretation, and reliable information management systems. Supplemental screening can also increase diagnostic recalls, with some published clinical protocols reporting rates around 10%. Additional assessment may involve targeted ultrasound, specialist consultation, or biopsy depending on imaging findings. Healthcare providers must therefore consider the balance between additional cancer detection and unnecessary investigations. Facilities with limited specialist availability may find implementation challenging, particularly when reimbursement arrangements do not adequately support supplemental screening procedures.

Clinical interpretation complexity represents another adoption barrier because automated examinations generate extensive image datasets requiring careful evaluation. GE HealthCare has reported a 33% improvement in reading efficiency with selected AI-assisted review tools, illustrating the operational burden that software developers are attempting to address. Without appropriate software support, radiologists may require additional time to navigate reconstructed breast volumes and investigate suspicious findings. Image artifacts and differences in breast positioning can also affect examination quality. Healthcare organizations must establish quality assurance procedures and suitable patient selection protocols. Training requirements and local regulatory conditions continue influencing purchasing decisions.

Opportunity

"Expanding diagnostic infrastructure creates opportunities for automated breast imaging."

Increasing investment in women's healthcare infrastructure creates opportunities for automated breast ultrasound systems. Asia-Pacific accounted for approximately 24% of the global market in a published regional assessment, highlighting its developing role in advanced breast imaging. Countries across the region are expanding diagnostic capacity, introducing screening awareness programs, and improving specialist healthcare accessibility. Automated scanning may support facilities seeking more standardized examinations across multiple locations. Manufacturers can strengthen participation through regional distribution, clinical training, and equipment maintenance partnerships. Demand is particularly relevant where established mammography services are expanding and healthcare providers are evaluating complementary imaging options.

Artificial intelligence and connected diagnostic platforms create additional opportunities for technology differentiation. GE HealthCare reported lesion detection sensitivity reaching 93% with its QVCAD-assisted breast ultrasound review technology under specified evaluation conditions. Such performance indicators encourage further investigation of software-assisted interpretation and clinical decision support. Manufacturers are developing applications for anatomical landmark recognition, image quality assessment, and structured reporting. Integration with picture archiving systems can improve collaboration between hospitals and diagnostic imaging laboratories. However, successful adoption requires independent clinical validation, regulatory compliance, and careful monitoring of performance across different patient populations.

Challenge

"Maintaining diagnostic consistency while managing complex imaging workflows."

Achieving consistent examination quality remains an important challenge for automated breast ultrasound manufacturers and healthcare providers. Breast anatomy, tissue density, positioning, and patient comfort can influence the completeness of image acquisition. GE HealthCare introduced scanning technology capable of improving acquisition speed by up to 40%, but faster examinations must maintain appropriate anatomical coverage and image quality. Technologists require training to recognize incomplete scans and adjust positioning when necessary. Radiologists must also distinguish genuine abnormalities from artifacts. Standardized examination protocols and quality assessment software are essential for maintaining dependable diagnostic workflows across different facilities.

Limited interoperability between imaging systems and clinical information platforms creates further operational challenges. Hospitals require secure communication between ultrasound workstations, electronic records, and radiology reporting applications. Philips reported that automated measurement tools within its broader ultrasound portfolio could reduce scanning time by up to 30% during evaluated workflows, illustrating the potential benefits of software integration. Although this performance figure is not specific to automated breast volume scanning, it demonstrates the wider industry's emphasis on efficiency. Facilities must also maintain cybersecurity safeguards, software updates, and equipment servicing. These requirements influence the long-term operational suitability of automated imaging investments.

Automated Breast Ultrasound Market Segmentation

Global Automated Breast Ultrasound Market Size, 2035

Get Comprehensive Insights on the Market Segmentation in this Report

download Download FREE Sample

By Types

Automated Breast Ultrasound System: Automated Breast Ultrasound System represents an established product category supporting standardized breast image acquisition and supplemental diagnostic evaluation. A published product assessment attributes approximately 63% of market activity to this category, although classifications differ across industry studies. These systems combine automated scanning mechanisms, ultrasound transducers, image reconstruction, and specialized viewing software. Healthcare providers use them to obtain reproducible breast images with reduced dependence on manual scanning techniques. Advanced platforms increasingly incorporate artificial intelligence for quality assessment and lesion review. Hospitals value their ability to integrate with established breast imaging workflows, support examination standardization, and provide additional information for selected patients with dense breast tissue.

Automated Breast Volume Scanner: Automated Breast Volume Scanner focuses on comprehensive volumetric breast imaging through structured ultrasound acquisition and reconstructed anatomical visualization. Within a complementary two-category allocation, the segment represents approximately 37% of the referenced product distribution. These systems produce image volumes that radiologists can examine in multiple planes, supporting assessment of breast structures and suspicious findings. The technology is particularly relevant for imaging facilities seeking standardized examinations and comprehensive visualization. Software improvements are strengthening reconstruction quality, workstation usability, and interpretation efficiency. Manufacturers are also emphasizing ergonomic transducer designs and patient positioning capabilities. Product selection depends on clinical performance, equipment compatibility, service availability, and examination requirements.

By Applications

Hospitals: Hospitals represent an important application within the Automated Breast Ultrasound Market because integrated healthcare facilities manage screening referrals, diagnostic investigations, and specialist consultations. The segment accounts for approximately 64% of the market within the two supplied application categories. Hospital imaging departments benefit from coordinated access to mammography, ultrasound, pathology, and multidisciplinary breast care services. Automated systems can improve examination standardization while supporting efficient clinical workflows. Purchasing decisions typically consider image quality, patient throughput, clinical training, and integration with existing information systems. Large hospital networks may also deploy shared reporting arrangements to support consistent interpretation across multiple locations.

Diagnostic Imaging Laboratories: Diagnostic Imaging Laboratories provide specialized breast imaging services for patients referred by clinicians or participating in organized screening pathways. The segment accounts for approximately 36% of the market within the two supplied application categories. These facilities increasingly evaluate automated ultrasound to improve examination consistency and manage growing appointment volumes. Dedicated imaging laboratories often prioritize scheduling efficiency, standardized protocols, and rapid report availability. Automated acquisition can support consistent image collection while radiologists perform detailed interpretation using specialized workstations. Remote reading capabilities may also improve access to experienced specialists. Commercial adoption depends on examination volumes, reimbursement conditions, equipment utilization, and dependable technical support.

Automated Breast Ultrasound Market Regional Outlook

Global Automated Breast Ultrasound Market Share, by Type 2035

Get Comprehensive Insights into the Market’s Size and Growth Trends

download Download FREE Sample

North America

North America leads the Automated Breast Ultrasound Market through established breast screening infrastructure, advanced diagnostic facilities, and increasing awareness of breast density. A published global market assessment attributes approximately 45% of market activity to the region. The United States remains the principal contributor, supported by specialized breast imaging centers and experienced radiology networks. Federal breast density notification requirements have strengthened discussions regarding supplemental screening, although imaging decisions remain dependent on individual risk and clinical guidance. Manufacturers are introducing advanced automated acquisition and remote interpretation technologies. Hospitals increasingly evaluate artificial intelligence integration and standardized examination protocols. Canada also contributes through established diagnostic healthcare systems and continued investment in breast imaging accessibility.

Europe

Europe represents an important Automated Breast Ultrasound Market supported by established breast screening programs, specialized diagnostic infrastructure, and continuing imaging technology modernization. Published research on automated whole-breast ultrasound attributes approximately 28% of regional market activity to Europe within its defined assessment. Germany, France, Italy, and the United Kingdom contribute through hospital imaging departments and specialist diagnostic facilities. Healthcare providers increasingly evaluate supplemental ultrasound for selected patients with dense breast tissue. Regulatory requirements and reimbursement arrangements vary between countries, influencing procurement decisions. Manufacturers emphasize reproducible imaging, reliable technical support, and compatibility with established radiology systems. Opportunities include upgraded screening infrastructure, improved interpretation software, and coordinated diagnostic services across healthcare networks.

Asia-Pacific

Asia-Pacific is becoming an increasingly important Automated Breast Ultrasound Market as healthcare systems expand diagnostic imaging capabilities and breast cancer awareness programs. Published automated whole-breast ultrasound research attributes approximately 23% of market activity to the region. China, Japan, India, and South Korea contribute through medical infrastructure development, diagnostic equipment adoption, and specialist healthcare services. Growing urban populations and increasing awareness of preventive examinations support demand for advanced breast imaging. Automated ultrasound can offer advantages in facilities seeking reproducible examination protocols. However, equipment affordability, specialist availability, and reimbursement differences influence adoption across individual countries. Regional manufacturers and distributors are developing partnerships to improve equipment accessibility, clinical training, and long-term maintenance support.

Middle East and Africa

The Middle East and Africa Automated Breast Ultrasound Market is developing alongside investments in diagnostic healthcare infrastructure and women's health services. Within a normalized planning distribution separating this region from other emerging territories, its allocation is approximately 3%, rather than an independently verified regional market share. Countries across the Gulf are strengthening hospital imaging capabilities and expanding access to specialist diagnostic services. Selected African healthcare systems are also developing breast screening and awareness initiatives. Automated ultrasound may provide additional diagnostic capabilities where mammography infrastructure is already available. However, equipment acquisition requirements, radiologist availability, and maintenance capabilities influence implementation. Regional development depends on healthcare investment, professional training, and sustainable access to diagnostic services.

Rest of the World

The Rest of the World Automated Breast Ultrasound Market encompasses additional territories where healthcare organizations are strengthening breast imaging capacity and specialist diagnostic accessibility. Within the complementary planning distribution, this grouping represents approximately 1% of global activity, although a directly comparable independently measured share is unavailable. Selected Latin American healthcare markets are expanding breast cancer awareness and modernizing diagnostic infrastructure. Automated ultrasound adoption remains influenced by equipment availability, clinical expertise, and local healthcare financing conditions. Hospitals and imaging laboratories may benefit from standardized scanning and remote interpretation capabilities. Manufacturers seeking wider participation must address distribution networks, technical maintenance, and training requirements. Continued diagnostic modernization may support gradual expansion across smaller healthcare markets.

List of Top Automated Breast Ultrasound Market Companies

  • General Electric Company
  • Hitachi, Ltd.
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • Telemed Medical Systems
  • Canon Medical Systems Corporation
  • Fukuda Denshi
  • Hologic, Inc.

Top Two Companies with Highest Market Share

  • General Electric Company: Through GE HealthCare, the business holds approximately 21% of the global Automated Breast Ultrasound Market, supported by its advanced Invenia ABUS technology and established diagnostic imaging presence.
  • Koninklijke Philips N.V.: The organization holds approximately 18% of the global Automated Breast Ultrasound Market, supported by advanced ultrasound imaging solutions, artificial intelligence integration, and established healthcare partnerships.

Investment Analysis and Opportunities

Investment in the Automated Breast Ultrasound Market increasingly focuses on advanced imaging platforms, artificial intelligence, and diagnostic infrastructure expansion. Approximately 40% of women undergoing mammography have dense breasts, creating a substantial clinical population for evaluating supplemental screening strategies. Healthcare organizations are assessing automated ultrasound systems according to clinical effectiveness, examination consistency, and operational requirements. Manufacturers are investing in improved transducers, automated image acquisition, and sophisticated reconstruction software. Cloud-based review capabilities create opportunities for coordinated interpretation across multiple facilities. Investment attractiveness depends on equipment utilization, reimbursement arrangements, regulatory authorization, and the availability of trained imaging professionals. Technologies capable of improving clinical workflow while maintaining reliable diagnostic performance may support wider adoption.

Expanding breast imaging accessibility creates additional opportunities for hospitals, diagnostic laboratories, and medical technology suppliers. GE HealthCare has reported a 33% reduction in interpretation time using selected AI-assisted automated breast ultrasound review tools. Such efficiency improvements may help organizations manage increasing examination volumes without relying exclusively on additional personnel. Investment priorities also include secure image transfer, workstation integration, remote reporting, and quality assurance software. Emerging healthcare markets offer opportunities through diagnostic infrastructure modernization and professional training partnerships. However, equipment procurement decisions require careful assessment of clinical evidence and patient outcomes. Sustainable development depends on integrating automated ultrasound into appropriate screening pathways rather than relying solely on technological capabilities.

New Product Development

New product development in the Automated Breast Ultrasound Market emphasizes improved image quality, examination speed, patient comfort, and artificial intelligence integration. GE HealthCare introduced its Invenia ABUS Prime platform with a Fast Scan function capable of improving scanning speed by up to 40% compared with the previous Invenia ABUS configuration. The system incorporates automated quality assessment, anatomical landmark recognition, and redesigned transducer technology. These improvements aim to simplify examination procedures while supporting reproducible breast image acquisition. Manufacturers are also developing more intuitive workstations and configurable image review tools. Product development increasingly addresses the practical requirements of large imaging networks, including consistent training, centralized reporting, and reliable software maintenance.

Artificial intelligence is becoming a central component of breast imaging software development across established medical technology companies. Koninklijke Philips N.V. introduced enhanced ultrasound workflow capabilities, with clinical evaluations reporting scanning time reductions of up to 30% for selected automated measurement tasks. Its broader imaging platform also incorporates artificial intelligence support for breast lesion assessment. Although conventional ultrasound decision support differs from dedicated automated breast volume acquisition, these developments demonstrate technological convergence across diagnostic imaging. Manufacturers are improving lesion characterization, image reconstruction, and reporting integration. Future product development will increasingly emphasize clinical validation, interoperability, and consistent performance across different patient populations. Appropriate regulatory authorization and professional interpretation remain essential for clinical deployment.

Five Recent Developments

  • April 2026 – Hologic Highlights Advanced Breast Cancer Detection: Hologic, Inc. presented research demonstrating that its artificial intelligence technology identified 43% of selected invasive lobular cancers previously interpreted as negative during mammography screening. The findings concerned mammography rather than automated breast ultrasound.
  • June 2026 – Philips Expands AI Ultrasound Imaging Capabilities: Koninklijke Philips N.V. announced regulatory clearance for Elevate Plus, introducing enhanced ultrasound automation and breast lesion assessment tools. Evaluated automated measurement workflows demonstrated scanning time reductions of up to 30%.
  • June 2026 – Canon Introduces Advanced Diagnostic Ultrasound Platform: Canon Medical Systems Corporation launched Aplio me X, strengthening its diagnostic ultrasound portfolio. The announcement occurred amid broader breast imaging demand associated with dense tissue, which affects approximately 40% of mammography patients in several studied populations.
  • August 2026 – GE Introduces Advanced Automated Breast Imaging: General Electric Company's healthcare successor, GE HealthCare, launched Invenia ABUS Prime and ABUS StreamVue. The new automated platform offers scanning speed improvements of up to 40%, supporting more efficient supplemental breast imaging workflows.
  • October 2026 – Siemens Refocuses Its Ultrasound Technology Portfolio: Siemens Healthineers AG announced a strategic shift toward procedural imaging, drawing on more than 25 years of intracardiac ultrasound development. The change includes discontinuing new general imaging ultrasound system sales while maintaining existing customer support.

Future Outlook of Automated Breast Ultrasound Market

The Automated Breast Ultrasound Market is expected to benefit from increasing breast cancer awareness, improved diagnostic infrastructure, and continued development of supplemental screening technologies. Healthcare organizations will increasingly evaluate automated imaging systems for examination consistency, patient accessibility, and integration with established mammography services. Artificial intelligence is expected to support image quality assessment, lesion review, and more efficient interpretation workflows. Manufacturers will continue improving transducer ergonomics, imaging software, and remote reporting capabilities. Adoption will nevertheless depend on appropriate clinical indications, professional training, regulatory requirements, and reimbursement conditions. Growing emphasis on personalized screening pathways may strengthen opportunities for technologies supporting reliable breast tissue evaluation.

Future market competition will increasingly emphasize diagnostic performance, workflow efficiency, and coordinated healthcare delivery. Automated breast ultrasound manufacturers are expected to expand investment in intelligent image reconstruction, standardized scanning protocols, and connected radiology platforms. Hospitals and diagnostic imaging laboratories will prioritize systems capable of supporting consistent examinations while maintaining patient comfort and professional oversight. Remote interpretation may help facilities improve access to specialist radiologists across geographically distributed healthcare networks. Emerging markets could offer additional opportunities as breast imaging infrastructure develops. Organizations combining clinically validated technology, reliable support services, and practical workflow integration will be better positioned to address evolving diagnostic requirements and patient expectations.

Automated Breast Ultrasound Market Report Coverage

REPORT COVERAGE DETAILS

Market Size Value In

USD 1593.39 Million in 2026

Market Size Value By

USD 5189.84 Million by 2035

Growth Rate

CAGR of 14.02% from 2026-2035

Forecast Period

2026 - 2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type :

  • Automated Breast Ultrasound System
  • Automated Breast Volume Scanner

By Application :

  • Hospitals
  • Diagnostic Imaging Laboratories

To Understand the Detailed Market Report Scope & Segmentation

download Download FREE Sample

Frequently Asked Questions

The global Automated Breast Ultrasound Market is expected to reach USD 5189.84 Million by 2035.

The Automated Breast Ultrasound Market is expected to exhibit a CAGR of 14.02% by 2035.

General Electric Company, Hitachi, Ltd., Koninklijke Philips N.V., Siemens Healthineers AG, Telemed Medical Systems, Canon Medical Systems Corporation, Fukuda Denshi, Hologic, Inc.

In 2026, the Automated Breast Ultrasound Market value will reach at USD 1593.39 Million.

faq right

Our Clients

Captcha refresh

Trusted & Certified